Inoviq (ASX:IIQ)
ASX announcement history & article coverage
Transparent by design.
Announcments by Inoviq (ASX:IIQ) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Appendix 4G and Corporate Governance Statement
Appendix 4E and Preliminary Financial Report
Becoming a substantial holder
Change of Director's Interest Notice
EXO-OC Study Outcome Investor Webinar Presentation
INOVIQ reports sample quality issues in EXO-OC ovarian cancer test study, commits to technical review and dual LDT-IVD commercialisation paths
Quarterly Activities Report and Appendix 4C - June 2026
INOVIQ reports clinical validation setback for EXO-OC test but advances algorithm and CAR-exosome program with strong cash position
Investor Briefing on EXO-OC Test and study outcome
EXO-OC algorithm and clinical study update
Trading Halt
Notification of cessation of securities - IIQ
Positive CAR-exosome data in ovarian cancer
INOVIQ demonstrates strong in vitro tumour killing in ovarian cancer with CAR-exosomes
Response to ASX Price Query
INOVIQ Limited attributes share price rise to third-party research note on clinical milestones, confirms no undisclosed information
